biomarkers
-
antipsychotics, biomarkers, brain metabolites, Editor Eimear Foley, first episode psychosis, glutamate, glutamatergic dysfunction, JAMA Psychiatry, mega-analysis, meta-analysis, neuroimaging, personalisation, personalised medicine, prediction, proton magnetic resonance spectroscopy, psychosis, schizophrenia, systematic review, treatment resistance, treatment responseCan brain metabolites predict who responds to antipsychotics?
Antipsychotics are the first choice of treatment for people with schizophrenia or…
-
biomarkers, Brain, depression, MDS-UPDRS, Neurodegenerative Diseases, non-motor symptoms, parkinson’s disease, PPMI, prodromal parkinsons disease, uric acidLower Uric Acid Predicted Depression in Prodromal Parkinson’s Disease
A 5-year PPMI cohort analysis found that lower serum uric acid independently…
-
Anxiety, APRIL, biomarkers, Cancer Disparities Research Network, chronic inflammation, gp130, health disparities, IL-6, mind-body, MMP-1, Psychiatry, Psychology, Stress, underserved populationsAnxiety Biomarkers: gp130, MMP-1, APRIL in 190 Adults
The link between psychological stress and chronic inflammation is well-documented — what’s…
-
biomarkers, Brain, cancer symptoms, cytokines, dexamethasone, dyspnea, Edmonton Symptom Assessment System, fatigue, inflammation, pain, palliative care, placebo response, Psychiatry, Psychology, trial designHigh Cytokines Predicted Weaker Placebo Response in Cancer Symptom Trial
A 2026 exploratory analysis of the ABCD cancer dyspnea trial found that…
